Your browser doesn't support javascript.
loading
Low versus standard calorie and protein feeding in ventilated adults with shock: a randomised, controlled, multicentre, open-label, parallel-group trial (NUTRIREA-3).
Reignier, Jean; Plantefeve, Gaetan; Mira, Jean-Paul; Argaud, Laurent; Asfar, Pierre; Aissaoui, Nadia; Badie, Julio; Botoc, Nicolae-Vlad; Brisard, Laurent; Bui, Hoang-Nam; Chatellier, Delphine; Chauvelot, Louis; Combes, Alain; Cracco, Christophe; Darmon, Michael; Das, Vincent; Debarre, Matthieu; Delbove, Agathe; Devaquet, Jérôme; Dumont, Louis-Marie; Gontier, Olivier; Groyer, Samuel; Guérin, Laurent; Guidet, Bertrand; Hourmant, Yannick; Jaber, Samir; Lambiotte, Fabien; Leroy, Christophe; Letocart, Philippe; Madeux, Benjamin; Maizel, Julien; Martinet, Olivier; Martino, Frédéric; Maxime, Virginie; Mercier, Emmanuelle; Nay, Mai-Anh; Nseir, Saad; Oziel, Johanna; Picard, Walter; Piton, Gael; Quenot, Jean-Pierre; Reizine, Florian; Renault, Anne; Richecoeur, Jack; Rigaud, Jean-Philippe; Schneider, Francis; Silva, Daniel; Sirodot, Michel; Souweine, Bertrand; Tamion, Fabienne.
Afiliação
  • Reignier J; Movement, Interactions, Performance, UR 4334, Nantes Université, Nantes, France; Médecine Intensive Réanimation, CHU de Nantes, Hôtel-Dieu, Nantes, France. Electronic address: jean.reignier@chu-nantes.fr.
  • Plantefeve G; Service de Médecine Intensive Réanimation, Centre Hospitalier d'Argenteuil, Argenteuil, France.
  • Mira JP; Service de Médecine Intensive Réanimation, Hôpital Cochin, Groupe Hospitalier Paris Centre-Université Paris Cité, AP-HP, Paris, France.
  • Argaud L; Service de Médecine Intensive Réanimation, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France.
  • Asfar P; Service de Médecine Intensive Réanimation, CHU Angers, Angers, France.
  • Aissaoui N; Service de Médecine Intensive Réanimation, Hôpital Européen Georges Pompidou, AP-HP, Paris, France.
  • Badie J; Service de Médecine Intensive Réanimation, Hôpital Nord Franche Comté, Trevenans, France.
  • Botoc NV; Service de Médecine Intensive Réanimation, Centre Hospitalier de Saint Malo, Saint-Malo, France.
  • Brisard L; Service d'Anesthésie RéanimationChirurgicale, Hôpital Laënnec, CHU de Nantes, Nantes, France.
  • Bui HN; Service de Médecine Intensive Réanimation, CHU de Bordeaux, Bordeaux, France.
  • Chatellier D; Service de Médecine Intensive Réanimation, CHU de Poitiers, Poitiers, France.
  • Chauvelot L; Service de Médecine Intensive Réanimation, Hôpital de la Croix Rousse, Hospices Civils de Lyon, Lyon, France.
  • Combes A; Service de Médecine Intensive Réanimation, Sorbonne Université, Inserm, UMRS 1166-ICAN, Institute of Cardiometabolism and Nutrition, Hôpital Pitié-Salpêtrière, AP-HP, Paris, France.
  • Cracco C; Service de Médecine Intensive Réanimation, Centre Hospitalier d'Angoulême, Angoulême, France.
  • Darmon M; Université Paris Cité, Service de Médecine Intensive Réanimation, CHU Saint Louis, AP-HP, Paris, France.
  • Das V; Service de Médecine Intensive Réanimation, Centre Hospitalier Intercommunal André Grégoire, Montreuil, France.
  • Debarre M; Service de Médecine Intensive Réanimation, Centre Hospitalier de Saint Brieuc, Saint Brieuc, France.
  • Delbove A; Service de Réanimation Polyvalente, Centre Hospitalier Bretagne-Atlantique, Vannes, France.
  • Devaquet J; Service de Réanimation Polyvalente, Hôpital Foch, Suresnes, France.
  • Dumont LM; Service de Médecine Intensive Réanimation, Hôpital Louis-Mourier, AP-HP, Colombes, France.
  • Gontier O; Service de Médecine Intensive Réanimation, Centre Hospitalier de Chartres, Chartres, France.
  • Groyer S; Service de Médecine Intensive Réanimation, Centre Hospitalier de Montauban, Montauban, France.
  • Guérin L; Service de Médecine Intensive Réanimation, CHU Bicêtre, AP-HP, Paris, France.
  • Guidet B; Sorbonne Université, Inserm, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Service de Médecine IntensiveRéanimation, Hôpital Saint Antoine, AP-HP, Paris, France.
  • Hourmant Y; CHU de Nantes, Inserm, Nantes Université, Anesthesie Reanimation, CIC 1413, Nantes, France.
  • Jaber S; Service de Réanimation Chirurgicale, Hôpital Saint-Eloi, CHU de Montpellier, Montpellier, France; PhyMedExp, Inserm, CNRS, Montpellier, France.
  • Lambiotte F; Service de Médecine Intensive Réanimation, Centre Hospitalier de Valenciennes, Valenciennes, France.
  • Leroy C; Service de Médecine Intensive Réanimation, Centre Hospitalier Emile Roux, Le Puy-en-Velay, France.
  • Letocart P; Service de Médecine Intensive Réanimation, Centre Hospitalier Jacques Puel, Rodez, France.
  • Madeux B; Service de Médecine Intensive Réanimation, Centre Hospitalier de Bigorre, Tarbes, France.
  • Maizel J; Service de Médecine Intensive Réanimation, CHU Amiens-Picardie, Amiens, France.
  • Martinet O; Service de Médecine Intensive Réanimation, CHU de la Réunion, Saint-Denis, La Réunion, France.
  • Martino F; Service de Médecine Intensive Réanimation, CHU de la Guadeloupe, Abymes, Guadeloupe, France.
  • Maxime V; Service de Médecine Intensive Réanimation, Hôpital Raymond Poincaré, AP-HP, Garches, France; Inserm U 1173, Université de Versailles-Saint Quentin en Yvelines, Versailles, France.
  • Mercier E; Service de Médecine Intensive Réanimation, CHU de Tours, CRICS-TRIGGERSEP Network Tours, France.
  • Nay MA; Service de Médecine Intensive Réanimation, Centre Hospitalier Régional d'Orléans, Orléans, France.
  • Nseir S; Médecine Intensive-Réanimation, CHU Lille, France; CNRS, Inserm, UMR 8576-U1285, Unité de Glycobiologie Structurale et Fonctionnelle, Université de Lille, France.
  • Oziel J; Service de Médecine Intensive Réanimation, Hôpital Avicenne, AP-HP, Bobigny, France.
  • Picard W; Service deMédecine Intensive Réanimation, Centre Hospitalier de Pau, Pau, France.
  • Piton G; Service de Médecine Intensive Réanimation, CHU de Besançon, Besançon, France; Université de Franche Comté, Equipe EA 3920, Besançon, France.
  • Quenot JP; Service de Médecine Intensive Réanimation, CHU François Mitterrand, Dijon, France; Lipness Team, Inserm, LabExLipSTIC France; Inserm Centres d'Investigation Clinique, Département d'Epidémiologie Clinique, Université de Bourgogne, Dijon, France.
  • Reizine F; Service de Médecine Intensive Réanimation, CHU de Rennes, Rennes, France.
  • Renault A; Service de Médecine Intensive Réanimation, CHU la Cavale Blanche, Brest, France.
  • Richecoeur J; Service de Médecine Intensive Réanimation, Centre Hospitalier de Beauvais, Beauvais, France.
  • Rigaud JP; Service de Médecine Intensive Réanimation, Centre Hospitalier de Dieppe, Dieppe, France.
  • Schneider F; Service de Médecine Intensive Réanimation, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
  • Silva D; Service de Médecine Intensive Réanimation, Hôpital Delafontaine, Saint-Denis, France.
  • Sirodot M; Service de Médecine Intensive Réanimation, Centre Hospitalier Annecy Genevois, Epagny Metz-Tessy, France.
  • Souweine B; Service de Médecine Intensive Réanimation, CHU Gabriel-Montpied, Clermont-Ferrand, France.
  • Tamion F; Service de Médecine Intensive Réanimation, Hôpital Charles Nicolle, CHU de Rouen, Normandie Université, UNIROUEN, Inserm U1096, FHU REMOD-VHF, Rouen, France.
Lancet Respir Med ; 11(7): 602-612, 2023 07.
Article em En | MEDLINE | ID: mdl-36958363
ABSTRACT

BACKGROUND:

The optimal calorie and protein intakes at the acute phase of severe critical illness remain unknown. We hypothesised that early calorie and protein restriction improved outcomes in these patients, compared with standard calorie and protein targets.

METHODS:

The pragmatic, randomised, controlled, multicentre, open-label, parallel-group NUTRIREA-3 trial was performed in 61 French intensive care units (ICUs). Adults (≥18 years) receiving invasive mechanical ventilation and vasopressor support for shock were randomly assigned to early nutrition (started within 24 h after intubation) with either low or standard calorie and protein targets (6 kcal/kg per day and 0·2-0·4 g/kg per day protein vs 25 kcal/kg per day and 1·0-1·3 g/kg per day protein) during the first 7 ICU days. The two primary endpoints were time to readiness for ICU discharge and day 90 all-cause mortality. Key secondary outcomes included secondary infections, gastrointestinal events, and liver dysfunction. The trial is registered on ClinicalTrials.gov, NCT03573739, and is completed.

FINDINGS:

Of 3044 patients randomly assigned between July 5, 2018, and 8 Dec 8, 2020, eight withdrew consent to participation. By day 90, 628 (41·3%) of 1521 patients in the low group and 648 (42·8%) of 1515 patients in the standard group had died (absolute difference -1·5%, 95% CI -5·0 to 2·0; p=0·41). Median time to readiness for ICU discharge was 8·0 days (IQR 5·0-14·0) in the low group and 9·0 days (5·0-17·0) in the standard group (hazard ratio [HR] 1·12, 95% CI 1·02 to 1·22; p=0·015). Proportions of patients with secondary infections did not differ between the groups (HR 0·85, 0·71 to 1·01; p=0·06). The low group had lower proportions of patients with vomiting (HR 0·77, 0·67 to 0·89; p<0·001), diarrhoea (0·83, 0·73 to 0·94; p=0·004), bowel ischaemia (0·50, 0·26 to 0·95; p=0·030), and liver dysfunction (0·92, 0·86-0·99; p=0·032).

INTERPRETATION:

Compared with standard calorie and protein targets, early calorie and protein restriction did not decrease mortality but was associated with faster recovery and fewer complications.

FUNDING:

French Ministry of Health.
Assuntos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Choque / Coinfecção Tipo de estudo: Clinical_trials / Etiology_studies Limite: Adult / Humans Idioma: En Revista: Lancet Respir Med Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Choque / Coinfecção Tipo de estudo: Clinical_trials / Etiology_studies Limite: Adult / Humans Idioma: En Revista: Lancet Respir Med Ano de publicação: 2023 Tipo de documento: Article